Y-Intercept (Hong Kong) Ltd

Position in VTRS — Viatris Inc

CIK 1772875 HONG KONG, K3

Position in VTRS

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$7,104,409

+$4,959,623 QoQ

Shares Held

525,863

+205.3% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Y-Intercept (Hong Kong) Ltd holds $31,681,893 across 15 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (22.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	302,995	$9,126,209
2	VTRS	Viatris Inc This page	525,863	$7,104,409
3	PRGO	PERRIGO Co plc	447,451	$4,805,623
4	BIOA	BioAge Labs, Inc.	201,337	$3,521,384
5	ZTS	Zoetis Inc.	15,837	$1,872,091
6	SUPN	Supernus Pharmaceuticals, Inc.	20,236	$1,045,998
7	HLN	Haleon plc	93,822	$939,158
8	XERS	Xeris Biopharma Holdings, Inc.	161,793	$938,399

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,104,409	525,863	+205.3%	Shares	Sole	2026-04-27
2025-12-31	$2,144,786	172,272	-51.4%	Shares	Sole	2026-02-13
2025-09-30	$3,508,203	354,364	+581.4%	Shares	Sole	2025-10-31
2025-06-30	$464,440	52,009	-29.0%	Shares	Sole	2025-08-01
2025-03-31	$638,364	73,291	+141.0%	Shares	Sole	2025-05-06
2024-12-31	$378,542	30,405	+136.5%	Shares	Sole	2025-02-04
2024-09-30	$149,281	12,858	-91.6%	Shares	Sole	2024-11-15
2024-03-31	$1,825,912	152,924	-5.2%	Shares	Sole	2024-05-10
2023-12-31	$1,746,348	161,251	+56.0%	Shares	Sole	2024-02-13
2022-12-31	$1,150,808	103,397	+54.3%	Shares	Sole	2023-02-14
2021-12-31	$906,658	67,011	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.